SCLERODERMA ENDURING MODULE

Clinical Management of Systemic Sclerosis: Hope and Reality

After attending this event, participants will be better able to:

Identify the symptom presentation of systemic sclerosis/scleroderma;
Consider the impact of systemic sclerosis on quality of life and the realistic outcomes of clinical management strategies;
Evaluate the various treatment options for systemic sclerosis to effectively treat what is treatable.

Speakers:

Janet Pope, MD, MPH, FRCPC

Professor, Department of Medicine

Epidemiology & Biostatistics

University of Western Ontario

London, ON

Robert Gniadecki, MD

Professor / Director, Department of Medicine

Division of Dermatology

University of Alberta

Edmonton, AB

Justin Kim, RN

Apheresis Clinic

Toronto General Hospital

Toronto, ON

This initiative has been sponsored in part by Mallinckrodt Pharmaceuticals through an educational grant.

WHAT YOU NEED TO KNOW ABOUT NEW THERAPIES FOR SYSTEMIC SCLEROSIS: A CASE-BASED APPROACH

After attending this event, participants will be better able to;

Recognize 3 pathogenic mechanisms in systemic sclerosis;
Consider newer medications to target each pathogenic process;
Understand that further medications are under investigation.

Speaker:

Maggie Larché, MBChB, MRCP(UK), PhD
Professor, Department of Medicine,
McMaster University
Director, Canadian Scleroderma Research Group
Hamilton, ON

This initiative has been sponsored in part by Pfizer Canada through an educational grant.

SCLERODERMA CASE-BASED WEBINAR

Clinical Management of Scleroderma: European & Canadian Perspectives

After attending this event, participants will be better able to;

Identify the symptom presentation of systemic sclerosis/scleroderma;
Consider the impact of systemic sclerosis on quality of life and the realistic outcomes of clinical management strategies;
Evaluate the various treatment options for systemic sclerosis.

SCLERODERMA ENDURING MODULE

Clinical Management of Systemic Sclerosis: Hope and Reality

After attending this event, participants will be better able to:

Identify the symptom presentation of systemic sclerosis/scleroderma;

Consider the impact of systemic sclerosis on quality of life and the realistic outcomes of clinical management strategies;

Evaluate the various treatment options for systemic sclerosis to effectively treat what is treatable.

Speakers:

This initiative has been sponsored in part by Mallinckrodt Pharmaceuticals through an educational grant.

WHAT YOU NEED TO KNOW ABOUT NEW THERAPIES FOR SYSTEMIC SCLEROSIS: A CASE-BASED APPROACH

After attending this event, participants will be better able to;

Recognize 3 pathogenic mechanisms in systemic sclerosis;

Consider newer medications to target each pathogenic process;

Understand that further medications are under investigation.

Speaker:

Maggie Larché, MBChB, MRCP(UK), PhD
Professor, Department of Medicine,
McMaster University
Director, Canadian Scleroderma Research Group
Hamilton, ON

This initiative has been sponsored in part by Pfizer Canada through an educational grant.

SCLERODERMA CASE-BASED WEBINAR

Clinical Management of Scleroderma: European & Canadian Perspectives

After attending this event, participants will be better able to;

Identify the symptom presentation of systemic sclerosis/scleroderma;

Consider the impact of systemic sclerosis on quality of life and the realistic outcomes of clinical management strategies;

Evaluate the various treatment options for systemic sclerosis.

Maggie Larché, MBChB, MRCP(UK), PhD
Professor, Department of Medicine,
McMaster University
Director, Canadian Scleroderma Research Group
Hamilton, ON

Jason J Lee, MD, PhD, FRCPC
Clinical Assistant Professor, Division of Rheumatology
University of Calgary
Calgary, AB

Martin Kaatz, MD
Department of Dermatology, SRH Wald-Klinikum
Gera GmbH, Gera, Germany

Moderator:

Speakers:

This initiative has been sponsored in part by Mallinckrodt Pharmaceuticals through an educational grant.